UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 3769

Change

+5.00 (+0.13)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-2.71 (-0.98%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.75 (-1.38%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+2.50 (+1.84%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.04 (+0.28%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.04 (+0.25%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.35 (-0.54%)

USD 266.08B
0QZO:LSE 0QZO

-0.75 (-0.78%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.12 (+0.41%)

USD 204.07B
0QZ3:LSE Qualcomm Inc.

-0.31 (-0.19%)

USD 202.26B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.65% 40% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.65% 40% F 47% F
Trailing 12 Months  
Capital Gain 11.92% 46% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.92% 46% F 50% F
Trailing 5 Years  
Capital Gain 14.78% 43% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.78% 43% F 51% F
Average Annual (5 Year Horizon)  
Capital Gain 7.55% 57% F 62% D
Dividend Return 7.55% 56% F 61% D-
Total Return 0.00% 14% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 12.80% 54% F 71% C-
Risk Adjusted Return 59.01% 66% D+ 78% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.